A Rare Cause of Hydrops Fetalis in Two Gaucher Disease Type 2 Patients with a Novel Mutation

Overview

Journal Metab Brain Dis

Publisher Springer

Specialties Endocrinology
Neurology

Date 2022 Mar 7

PMID 35254599

Authors

Sebile Kilavuz

Murat Basaranoglu

Serdar Epcacan

Derya Bako

Arife Ozer

Yasemin Nuran Donmez

Emine Ipek Ceylan

Ajlan Tukun

Serdar Ceylaner

Hadi Geylani

Halise Neslihan Onenli Mungan

Affiliations

Soon will be listed here.

Abstract

Gaucher disease type 2 is the most progressive and the rarest form of Gaucher disease, defined as the acute neuronopathic type. We presented two GD2 patients who died before three months of age due to severe septicemia, respiratory and liver failure. One was homozygous for a novel GBA variant c.590 T > A (p.197 K), and the second homozygous for the known GBA mutation c.1505G > A (p.R502H). Ichthyosis, hydrops fetalis, apnea, myoclonic seizures, and hepatosplenomegaly occurred in both patients, but hypertrophic cardiomyopathy was observed only in the second and unilateral cataract in the first patient. Due to the disease's early and rapid neurological progression, we did not administer ERT to our patients. It is strongly believed that early diagnosis is essential, and prenatal diagnosis makes genetic counselling possible for future pregnancies.

Citing Articles

Gaucher disease type 3c: Expanding the clinical spectrum of an ultra-rare disease.

Wang J, Koch R, Kenney-Jung D, Huggins E, Sodhi S, Landstrom A JIMD Rep. 2024; 65(5):313-322.

PMID: 39544691 PMC: 11558466. DOI: 10.1002/jmd2.12440.

The molecular mechanism of Gaucher disease caused by compound heterozygous mutations in gene.

Liu Q, Shen Z, Pan H, Ma S, Xiong F, He F Front Pediatr. 2023; 11:1092645.

PMID: 36776904 PMC: 9909548. DOI: 10.3389/fped.2023.1092645.

An Overview of Molecular Mechanisms in Fabry Disease.

Amodio F, Caiazza M, Monda E, Rubino M, Capodicasa L, Chiosi F Biomolecules. 2022; 12(10).

PMID: 36291669 PMC: 9599883. DOI: 10.3390/biom12101460.

References

Akdag A, Oguz S, Ezgu F, Erdeve O, Uras N, Dilmen U . A newborn case with perinatal-lethal Gaucher disease due to R463H homozygosity complicated by C677T homozygosity in the MTHFR gene. J Pediatr Endocrinol Metab. 2011; 24(5-6):381-3. DOI: 10.1515/jpem.2011.001. View

Alfonso P, Aznarez S, Giralt M, Pocovi M, Giraldo P . Mutation analysis and genotype/phenotype relationships of Gaucher disease patients in Spain. J Hum Genet. 2007; 52(5):391-396. DOI: 10.1007/s10038-007-0135-4. View

BenHamida E, Ayadi I, Ouertani I, Chammem M, Bezzine A, BenTmime R . Perinatal-lethal Gaucher disease presenting as hydrops fetalis. Pan Afr Med J. 2015; 21:110. PMC: 4546719. DOI: 10.11604/pamj.2015.21.110.7052. View

Bronstein S, Karpati M, Peleg L . An update of Gaucher mutations distribution in the Ashkenazi Jewish population: prevalence and country of origin of the mutation R496H. Isr Med Assoc J. 2015; 16(11):683-5. View

Bulut F, Kor D, Seker-Yilmaz B, Herguner O, Ceylaner S, Ozkinay F . Four Gaucher disease type II patients with three novel mutations: a single centre experience from Turkey. Metab Brain Dis. 2018; 33(4):1223-1227. DOI: 10.1007/s11011-018-0236-0. View

Campbell P, Harris C, Sirimanna T, Vellodi A . A model of neuronopathic Gaucher disease. J Inherit Metab Dis. 2004; 26(7):629-39. DOI: 10.1023/b:boli.0000005619.14180.5c. View

Daykin E, Ryan E, Sidransky E . Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes. Mol Genet Metab. 2021; 132(2):49-58. PMC: 7884077. DOI: 10.1016/j.ymgme.2021.01.002. View

Eblan M, Goker-Alpan O, Sidransky E . Perinatal lethal Gaucher disease: a distinct phenotype along the neuronopathic continuum. Fetal Pediatr Pathol. 2006; 24(4-5):205-22. DOI: 10.1080/15227950500405296. View

Grace M, Balwani M, Nazarenko I, Prakash-Cheng A, Desnick R . Type 1 Gaucher disease: null and hypomorphic novel chitotriosidase mutations-implications for diagnosis and therapeutic monitoring. Hum Mutat. 2007; 28(9):866-73. DOI: 10.1002/humu.20524. View

10.

Haverkaemper S, Marquardt T, Hausser I, Timme K, Kuehn T, Hertzberg C . Congenital ichthyosis in severe type II Gaucher disease with a homozygous null mutation. Neonatology. 2011; 100(2):194-7. DOI: 10.1159/000324116. View

11.

Inui K, Yanagihara K, Otani K, Suzuki Y, Akagi M, Nakayama M . A new variant neuropathic type of Gaucher's disease characterized by hydrocephalus, corneal opacities, deformed toes, and fibrous thickening of spleen and liver capsules. J Pediatr. 2001; 138(1):137-9. DOI: 10.1067/mpd.2001.109789. View

12.

Koprivica V, Stone D, Park J, Callahan M, Frisch A, Cohen I . Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. Am J Hum Genet. 2000; 66(6):1777-86. PMC: 1378059. DOI: 10.1086/302925. View

13.

Lui K, Commens C, Choong R, Jaworski R . Collodion babies with Gaucher's disease. Arch Dis Child. 1988; 63(7):854-6. PMC: 1779077. DOI: 10.1136/adc.63.7.854. View

14.

Migita M, Hamada H, Fujimura J, Watanabe A, Shimada T, Fukunaga Y . Glucocerebrosidase level in the cerebrospinal fluid during enzyme replacement therapy--unsuccessful treatment of the neurological abnormality in type 2 Gaucher disease. Eur J Pediatr. 2003; 162(7-8):524-525. DOI: 10.1007/s00431-001-0859-7. View

15.

Mignot C, Gelot A, Bessieres B, Daffos F, Voyer M, Menez F . Perinatal-lethal Gaucher disease. Am J Med Genet A. 2003; 120A(3):338-44. DOI: 10.1002/ajmg.a.20117. View

16.

Nagappa M, Bindu P, Taly A, Sinha S . Oculomotor apraxia in Gaucher disease. Pediatr Neurol. 2015; 52(4):468-9. DOI: 10.1016/j.pediatrneurol.2014.10.016. View

17.

Plakkal N, Soraisham A, Jirapradittha J, Pinto-Rojas A . Perinatal lethal Gaucher disease. Indian J Pediatr. 2010; 78(1):106-8. DOI: 10.1007/s12098-010-0247-2. View

18.

Roshan Lal T, Seehra G, Steward A, Poffenberger C, Ryan E, Tayebi N . The natural history of type 2 Gaucher disease in the 21st century: A retrospective study. Neurology. 2020; 95(15):e2119-e2130. PMC: 7713752. DOI: 10.1212/WNL.0000000000010605. View

19.

Staretz-Chacham O, Lang T, Lamarca M, Krasnewich D, Sidransky E . Lysosomal storage disorders in the newborn. Pediatrics. 2009; 123(4):1191-207. PMC: 2768319. DOI: 10.1542/peds.2008-0635. View

20.

Stone D, Carey W, Christodoulou J, Sillence D, Nelson P, Callahan M . Type 2 Gaucher disease: the collodion baby phenotype revisited. Arch Dis Child Fetal Neonatal Ed. 2000; 82(2):F163-6. PMC: 1721053. DOI: 10.1136/fn.82.2.f163. View